Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hipoglós is a well-established over-the-counter (OTC) topical ointment primarily used for the prevention and treatment of diaper dermatitis (diaper rash) and other minor skin irritations. Developed and marketed by Laboratorios Andromaco, the formulation typically combines zinc oxide, which serves as a protective physical barrier and mild astringent, with vitamins A (retinol) and D (ergocalciferol) to support skin regeneration and epithelial health. It is widely utilized in Latin American markets as a standard care product for infant skin protection and the management of superficial wounds or burns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hipoglós.